Plasmas Show Promise As Next Step For Accelerators

Date: November 23, 1992 Even as the superconducting supercollider survives another funding battle and lurches toward completion, some physicists are already wondering what comes next. The power of SSC collisions will fall far short of re-creating the state of matter at the instant the universe was born--an eventual goal of particle physicists. In order to give high- energy colleagues a new generation of tools to continue probing the mysteries of matter, a few plasma physicists are working on

Written byTom Abate
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Date: November 23, 1992

Even as the superconducting supercollider survives another funding battle and lurches toward completion, some physicists are already wondering what comes next.

The power of SSC collisions will fall far short of re-creating the state of matter at the instant the universe was born--an eventual goal of particle physicists. In order to give high- energy colleagues a new generation of tools to continue probing the mysteries of matter, a few plasma physicists are working on a revolutionary type of particle accelerator that uses the new, powerful, ultra-fast pulse lasers to achieve particle acceleration. This new technology has potential applications in the life sciences, as well.

The funding for developing alternative particle accelerators is not especially abundant, with the De- partment of Energy devoting about $5 million a year to the effort, but the possible first demonstration of laser particle acceleration made in a University of California, Los ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies